Overview

A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of sertraline compared to paroxetine in patients with panic disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Paroxetine
Sertraline